HCV Infection and the Incidence of CKD

被引:85
作者
Butt, Adeel A. [1 ,2 ,3 ]
Wang, Xiaoqiang [2 ,3 ]
Fried, Linda F. [2 ,3 ]
机构
[1] Univ Pittsburgh, Med Ctr, Sch Med, Pittsburgh, PA 15213 USA
[2] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[3] Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA
关键词
Hepatitis C virus (HCV); chronic kidney disease (CKD); renal; liver disease; Electronically Retrieved Cohort of HCV Infected Veteran (ERCHIVES); HEPATITIS-C VIRUS; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; SUBSTANCE-ABUSE; INCREASED RISK; PREVALENCE; LIVER; ASSOCIATION; PREDICTORS;
D O I
10.1053/j.ajkd.2010.09.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The risk of hepatitis C virus (HCV) infection upon incident chronic kidney disease (CKD) in the presence of traditional risk factors and renal-modifying therapy is not well known. Study Design: National cohort study. Study Design: National cohort study. Setting & Participants: HCV-infected and -uninfected veterans in ERCHIVES (Electronically Retrieved Cohort of HCV Infected Veterans) in 2001-2006. Predictor: HCV infection. Outcomes: Incident CKD stages 3-5 Results: We identified 18,002 patients with HCV infection and 25,137 controls with estimated glomerular filtration rate >60 mL/min/1.73 m(2) at baseline. HCV-infected patients had a lower prevalence of several CKD risk factors, including diabetes (22.9% vs 26.6%), hypertension (52.4% vs 60.8%), and dyslipidemia (39.3% vs 73.9%; P < 0.001). HCV infection was associated with a higher risk of developing CKD stages 3-5 (HR, 1.30; 95% CI, 1.23-1.37). Increasing age, hypertension, and diabetes were associated with significantly higher risks of developing CKD in HCV-infected patients and controls. Decompensated liver disease was a strong predictor of CKD in HCV-infected patients (HR, 3.37; 95% CI, 3.10-3.66) and HCV-uninfected controls (HR, 2.04; 95% CI, 1.84-2.25). In Kaplan-Meier analysis, HCV-infected persons had a shorter time to CKD. Limitations: Lack of proteinuria data; small number of women. Conclusions: HCV infection is associated with higher risk and shorter time to CKD despite having a lower prevalence of many CKD risk factors. HCV-infected persons should have targeted monitoring for the development and progression of CKD. Am J Kidney Dis. 57(3): 396-402. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.
引用
收藏
页码:396 / 402
页数:7
相关论文
共 27 条
[1]   Review article: hepatitis C virus-associated steatosis - pathogenic mechanisms and clinical implications [J].
Adinolfi, LE ;
Durante-Mangoni, E ;
Zampino, R ;
Ruggiero, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 :52-55
[2]   Hepatitis C infection is acquired pre-ESRD [J].
Bergman, S ;
Accortt, N ;
Turner, A ;
Glaze, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (04) :684-689
[3]   Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans [J].
Butt, A. A. ;
Khan, U. A. ;
McGinnis, K. A. ;
Skanderson, M. ;
Kwoh, C. Kent .
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (12) :890-896
[4]   Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects [J].
Butt, A. A. ;
Justice, A. C. ;
Skanderson, M. ;
Good, C. ;
Kwoh, C. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (04) :585-591
[5]   Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis [J].
Butt, AA ;
Evans, R ;
Skanderson, M ;
Shakil, AO .
JOURNAL OF HEPATOLOGY, 2006, 44 (05) :864-868
[6]   Rate and predictors of treatment prescription for hepatitis C [J].
Butt, Adeel A. ;
Justice, Amy C. ;
Skanderson, Melissa ;
Rigsby, Michael O. ;
Good, Chester B. ;
Kwoh, C. Kent .
GUT, 2007, 56 (03) :385-389
[7]   Hepatitis C treatment completion rates in routine clinical care [J].
Butt, Adeel A. ;
McGinnis, Kathleen A. ;
Skanderson, Melissa ;
Justice, Amy C. .
LIVER INTERNATIONAL, 2010, 30 (02) :240-250
[8]   Concluding remarks: metabolic syndrome, liver and HCV [J].
Cortez-Pinto, H .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 :83-85
[9]   Hepatitis C infection and the patient with end-stage renal disease [J].
Fabrizi, F ;
Poordad, FF ;
Martin, P .
HEPATOLOGY, 2002, 36 (01) :3-10
[10]   National surveillance of dialysis-associated diseases in the United States, 2002 [J].
Finelli, L ;
Miller, JT ;
Tokars, JI ;
Alter, MJ ;
Arduino, MJ .
SEMINARS IN DIALYSIS, 2005, 18 (01) :52-61